BMRA - Latest News
Biomerica, Inc. (BMRA), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $7.4M. Beta to the broader market is 0.28.
The article list below shows the most recent BMRA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent BMRA Headlines
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
globenewswire.com - May 28, 2026
Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy
Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
globenewswire.com - Apr 29, 2026
Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world's largest GI medical conference, May
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
globenewswire.com - Apr 16, 2026
Company and Laboratory Partner Believe Properly Documented Claims Are Positioned for Payment Under Existing $300 CMS Reimbursement Rate Company and La
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
globenewswire.com - Apr 14, 2026
— Represents Biomerica's First Commercial Entry into the Canadian Market for its Precision, Diagnostic-Guided Therapy — Canada Has One of the Highest
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
globenewswire.com - Apr 13, 2026
IRVINE, Calif. , April 13, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc.
How News Affects BMRA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BMRA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked BMRA news questions
- What is the latest BMRA news headline?
- The most recent BMRA headline (May 28, 2026) is "Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the BMRA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What BMRA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual BMRA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.